Big news: The American Medical Association adopted a new policy position
today calling for the review of marijuana’s status as a Schedule I drug.

The revised policy “urges that marijuana’s status as a federal Schedule I
controlled substance be reviewed with the goal of facilitating the conduct of
clinical research and development of cannabinoid-based medicines, and alternate
delivery methods.”

While it goes on to explain that the AMA is not stating
support for state medical marijuana laws, the new policy does fall in line with
what is quickly becoming a universal understanding in American medicine:
Marijuana has undeniable medical uses and federal law should reflect that

The new policy marks a historic shift from the AMA’s previous position, which
recommended that “marijuana be retained in Schedule I,” grouping marijuana with
drugs such as heroin, LSD, and PCP that are deemed to have no accepted medical

The AMA’s previous position was often cited by medical marijuana opponents as
evidence that the drug’s medical efficacy was in question. This new policy will
go a long way to convincing politicians and policy makers that the compassionate
use of medical marijuana should not be blocked by outdated marijuana laws.